Alto Marketing Limited

Cresset Group, Isogenica and Biolauncher have announced funding from the Technology Strategy Board, the UK’s innovation agency, for a £1M project to develop a highly-scalable approach to small molecule drug discovery.

Learn about the implications of efficiency in IDT’s satellite symposium at ESHG 2012

The largest ever genomic study of relapsed acute lymphoblastic leukaemia will fund Population Genetics Technologies Ltd to identify the genetic factors in resistance to treatment.

Bringing Science to the Fingertips of Computational and Medicinal Chemists

Improving custom bait design to increase accuracy, sensitivity and coverage depth.

Speeding up research with novel cell manipulation and analysis platforms

AIC to distribute Link’s specialist oligonucleotide modifiers in North America

Liquid Handling & Robotics Conference Stream at ELA 2012

Customer interest included standing-room-only presentation discussing data generated using sam® biosensors

Meeting the requirements of the evolving drug discovery pipeline